A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL ... disease in a relatively immature (also termed 'blast') state. Science X Daily and the Weekly ...

For people with MDS whose bone marrow has a large number of blast cells, doctors may use therapy for acute leukemia. This is particularly likely if the goal is to decrease the bone marrow blast count ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Scientists at City of Hope, a prominent cancer research and treatment institution in the U.S., have unveiled a novel approach to targeting and eliminating resilient leukemia stem cells, according ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

Patients with acute myeloid leukemia who relapse after stem cell transplantation have just a small chance of survival: doctors can give them additional donor T cells to fight the cancer, but only ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.